Screening behavior in women at increased familial risk for breast cancer.
This multicenter study examined the adherence of high-risk women to screening recommendations for breast and ovarian cancer following consultation at a familial cancer clinic (FCC). Self-report questionnaires assessing recall of screening advice, tests undertaken, risk perception, anxiety (Impact of Events Scale) and demographics were mailed to 396 consecutive eligible women who had attended one of six FCCs a median of 3.6 years prior. Family history, genetic test results and screening recommendations were abstracted from medical records. 182/266 (68.4%) women responded with 130 lost to follow-up. The proportions of women undertaking at least the recommended frequency of screening tests were: breast self examination (BSE) 50.4%, clinical breast examination (CBE) 66.0%, mammography 82.2%, transvaginal ultrasound (TVUS) 70.0%, CA125 84.0%. Factors associated with adherence to screening were: higher anxiety for BSE and CBE, being BRCA1/2 positive for CBE, older age, method of arrangement and having at least one affected first degree relative for mammography. Factors significantly associated with over-adherence were higher scores for anxiety for BSE and CBE and younger age (< 40 years) for TVUS. Between 41.3% (BSE) and 57.6% (CBE) of women incorrectly recalled their screening recommendations. A substantial minority of high-risk women do not adhere to screening advice. Strategies to improve the accuracy of recall of recommendations and the uptake of recommended screening are required.
Antill
Yoland C
YC
Department of Hematology and Medical Oncology, Peter MacCallum Cancer Centre, Locked Bag 1, Melbourne, Victoria, 8006, Australia.
Reynolds
John
J
Young
Mary Anne
MA
Kirk
Judy A
JA
Tucker
Katherine M
KM
Bogtstra
Tarli L
TL
Wong
Shirley S
SS
Dudding
Tracy E
TE
Di Iulio
Juliana L
JL
Phillips
Kelly-Anne
KA
D000328:Adult; D000368:Aged; D001943:Breast Neoplasms / Q000175:diagnosis* / Q000235:genetics / Q000523:psychology; D016504:Breast Self-Examination; D018394:CA-125 Antigen / Q000097:blood; D005260:Female; D006801:Humans; D008327:Mammography; D008875:Middle Aged; D010051:Ovarian Neoplasms / Q000175:diagnosis* / Q000235:genetics / Q000523:psychology; D010349:Patient Compliance; D012306:Risk
D018394:CA-125 Antigen